image credit: Freepik

Johnson & Johnson, Moderna COVID-19 vaccines work as intended, FDA staff say ahead of high-stakes booster meeting

October 13, 2021


Millions of people who received the Pfizer COVID-19 vaccine have been eligible to get a third booster dose for weeks, but those who received the other FDA-authorized shots have been waiting to see whether they’ll need another dose. They’ll soon have answers.

FDA vaccine advisors are set to meet Thursday and Friday to discuss the prospect of giving a third Moderna shot six months after the primary two-dose series and a second jab two months after Johnson & Johnson’s single-dose vaccine, respectively. In documents released ahead of the meeting, the companies presented their cases in favor of more doses, while FDA staff said the vaccines are already working as authorized.

Read More on FiercePharma